[Ip-health] 7/29: Conf Call: Pharma: The Emerging Market as a Partners

[Sarah Rimmington]

From: Council on Foreign Relations Corporate Program <corporate@cfr.org>
Reply-To: <corporate@cfr.org>
Date: Wed, 23 Jul 2008 15:56:02 -0400
To: "pdavis@healthgap.org" <pdavis@healthgap.org>
Subject: CFR Corporate Program Conference Call: 7/29, "The Global Outlook of
Pharma" with Robert Mallett, Pfizer

COUNCIL ON FOREIGN RELATIONS
CORPORATE PROGRAM
Tel 212 434 9684  Fax 212 434 9862

On behalf of the Council on Foreign Relations Corporate Program

**CONFERENCE CALL**
THE GLOBAL OUTLOOK OF PHARMA: THE EMERGING MARKET AS A PARTNER

ROBERT MALLETT
Senior Vice President,
Worldwide Public Affairs and Policy,
Pfizer
President, Pfizer Foundation

RICK EDMUNDS
Vice President,
Head of North American Life Sciences Sector,
Booz Allen Hamilton
will moderate

**Please note special time**
3:00 p.m. ET, Tuesday, July 29, 2008, for approx. 45 minutes

The emerging market was once viewed by the pharmaceutical industry through
the lens of patent infringement and corporate philanthropy, but has steadily
become seen as a place of innovation as well as an opportunity to impact in
a sustainable fashion some of the world's largest health crises. Research
and development centers are increasingly outsourced to the emerging market,
and it is estimated that 15% of clinical trials will take place in India by
2011. Global revenue in rapidly growing emerging markets is creating strong
revenue channels. At the same time, the pharmaceutical industry is
increasingly vested in being a partner in tackling diseases that plague
emerging markets by investing in local capacity building. Given this
globalized marketplace, what are the strategic priorities when it comes to
emerging markets? How do they fit into the overall growth models for this
sector? Join Robert Mallett and Rick Edmunds in discussing these issues and
more.

Mr. Robert L. Mallett is Senior Vice President for Worldwide Policy and
Public Affairs and President of the Pfizer Foundation. He directs Pfizer's
global policy and industry economics group, philanthropy and corporate
giving department. He is also an elected officer of the corporation. Prior
to joining Pfizer in April 2001, Mr. Mallett served as a visiting professor
at Harvard's JFK School of Government and served in the Clinton
Administration as Deputy Secretary of the U.S. Department of Commerce. He is
an attorney and has been a partner and associate in law firms in Washington,
D.C., as well as having served as legal counsel to former United States
Senator Lloyd Bentsen. Mr. Mallett is a member of the Council on Foreign
Relations, an elected Fellow of the National Academy of Public
Administrators, Chairman of the U.S.-South Africa Business Council, and a
member of the Board of Directors of Medical Education of South African
Blacks (MESAB). Mr. Mallett is a Phi Beta Kappa graduate of Morehouse
College (1979) and received his law degree from Harvard University in 1982,
where he was Projects Editor of the Harvard Civil Right-Civil Liberties Law
Review. He resides in New York City.

To register, please email the form below with questions or topics you would
like to be covered, as soon as possible.

Name:
Title:
Company/Affiliation:
Telephone:
Email:

* Topics/questions I would particularly like covered:

HOW TO PARTICIPATE
Please complete this form and email it to corporate@cfr.org. You will
receive an email confirming your participation along with dial-in
instructions prior to the call. Mr. Mallett will make brief remarks before
fielding questions from participants. The call will run for about forty-five
minutes. If you have any questions pertaining to this call, please contact
the Corporate Program office at 212-434-9684.



------ End of Forwarded Message

--
Sarah Rimmington
Attorney
Essential Action, Access to Medicines Project
Washington, DC
Tel: (202) 387-8030
Cell: (202) 422-2687
www.essentialaction.org/access/